The Current Ratio as of September 2024 (TTM) for Adial Pharmaceuticals, Inc. (ADIL) is 5.69

According to Adial Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.69. This represents a change of 2.43% compared to the average of 5.56 of the last 4 quarters.

Adial Pharmaceuticals, Inc. (ADIL) Historical Current Ratio (quarterly & annually)

How has ADIL Current Ratio performed in the past?

The mean historical Current Ratio of Adial Pharmaceuticals, Inc. over the last ten years is 5.58. The current 5.69 Current Ratio has changed 10.10% with respect to the historical average. Over the past ten years (40 quarters), ADIL's Current Ratio was at its highest in in the March 2019 quarter at 36.61. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Adial Pharmaceuticals, Inc. (ADIL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Adial Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adial Pharmaceuticals, Inc. (ADIL) Average Current Ratio

How has ADIL Current Ratio performed in the past?

The current Current Ratio of Adial Pharmaceuticals, Inc. (ADIL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Adial Pharmaceuticals, Inc. (ADIL) Current Ratio vs. Peers

How is ADIL’s Current Ratio compared to its peers?

Adial Pharmaceuticals, Inc.’s Current Ratio is greater than TransCode Therapeutics, Inc. (1.25), greater than Aditxt, Inc. (0.07), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than Avenue Therapeutics, Inc. (4.30), greater than Applied Molecular Transport Inc. (4.99), greater than Catalyst Biosciences, Inc. (0), greater than Aileron Therapeutics, Inc. (4.69), greater than Bio-Path Holdings, Inc. (1.67), greater than Benitec Biopharma Inc. (4.18), less than Hoth Therapeutics, Inc. (14.62), greater than Revelation Biosciences, Inc. (1.10), greater than NeuroBo Pharmaceuticals, Inc. (2.94), less than Virax Biolabs Group Limited (25.94), greater than RenovoRx, Inc. (4.39), greater than Axcella Health Inc. (0.80), greater than Better Therapeutics, Inc. (0.57), less than Pasithea Therapeutics Corp. (6.20), greater than Onconova Therapeutics, Inc. (1.93), less than Diffusion Pharmaceuticals Inc. (10.96), less than Aeterna Zentaris Inc. (5.94), greater than Tonix Pharmaceuticals Holding Corp. (1.15),

Build a custom stock screener for Adial Pharmaceuticals, Inc. (ADIL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adial Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adial Pharmaceuticals, Inc. (ADIL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adial Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.